Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Additivity predicts the efficacy of most approved combination therapies for advanced cancer

View ORCID ProfileHaeun Hwangbo, View ORCID ProfileSarah Patterson, View ORCID ProfileAndy Dai, View ORCID ProfileDeborah Plana, View ORCID ProfileAdam C. Palmer
doi: https://doi.org/10.1101/2022.10.21.22281013
Haeun Hwangbo
1Department of Pharmacology, Computational Medicine Program, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
2Curriculum in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Haeun Hwangbo
Sarah Patterson
1Department of Pharmacology, Computational Medicine Program, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah Patterson
Andy Dai
3North Carolina School of Science and Mathematics, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andy Dai
Deborah Plana
4Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Deborah Plana
Adam C. Palmer
1Department of Pharmacology, Computational Medicine Program, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adam C. Palmer
  • For correspondence: palmer{at}unc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: October 2022 to July 2025

AbstractFullPdf
Oct 2022297739
Nov 2022274123
Dec 202269012
Jan 202374113
Feb 202354323
Mar 202349111
Apr 2023239433
May 2023118925
Jun 202349910
Jul 2023312515
Aug 2023291610
Sep 202333119
Oct 2023493125
Nov 20231345294
Dec 2023702861
Jan 2024342131
Feb 2024351932
Mar 2024264433
Apr 2024303430
May 2024284174
Jun 2024212761
Jul 2024262950
Aug 2024191325
Sep 2024361543
Oct 2024272944
Nov 2024191951
Dec 202423753
Jan 202524751
Feb 2025237633
Mar 2025449841
Apr 2025267748
May 2025326465
Jun 2025426942
Jul 202594833
Back to top
PreviousNext
Posted April 13, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Additivity predicts the efficacy of most approved combination therapies for advanced cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Additivity predicts the efficacy of most approved combination therapies for advanced cancer
Haeun Hwangbo, Sarah Patterson, Andy Dai, Deborah Plana, Adam C. Palmer
medRxiv 2022.10.21.22281013; doi: https://doi.org/10.1101/2022.10.21.22281013
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Additivity predicts the efficacy of most approved combination therapies for advanced cancer
Haeun Hwangbo, Sarah Patterson, Andy Dai, Deborah Plana, Adam C. Palmer
medRxiv 2022.10.21.22281013; doi: https://doi.org/10.1101/2022.10.21.22281013

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)